Combined factor VIII and immunosuppressive treatment in a young woman with acquired factor VIII inhibitor;TRATAMIENTO COMBINADO CON FACTOR VIII E INMUNOSUPRESORES EN MUJER JOVEN CON INHIBIDOR ADQUIRIDO DEL FACTOR VIII

Sangre

Volumn 41, Issue 2, 1996, Pages 147-150

  Aguado, María José ^a   Carrasco, Vicente ^a   Periago, Adela ^a   Bello, Teófilo ^a   González, Enrique ^a   García Talavera, Juan ^a  

^a Carretera del Rosario   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 INHIBITOR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING; CASE REPORT; FEMALE; HEMOPHILIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION;

ADULT; AUTOANTIBODIES; AUTOIMMUNE DISEASES; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FACTOR VIII; FEMALE; HEMORRHAGIC DISORDERS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PARITY; PREDNISONE; VINCRISTINE;

EID: 0029948962     PISSN: 00364355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Morrison AE, Ludlarn CA. The use of porcine factor VIII in the treatment of patients with acquired hemophilia: The United Kingdom Experience. Am J Med 1991; 91 (suppl 5) 23-26.
2. Lottenburg R, KentroTB. Kitchns CS. Acquired hemophilia. A natural history study of 16 patients with factor VIII inhbitor receiving little or no therapy Arch Intern Med 1987: 147- 1077-1081.
3. Shitamoto BS, Leslie KO, Galloway WB Pospartum hemophilia. Am J Clin Pathol 1982; 78: 789-791.
4. Lottenberg R, Kentro TB, Kitchens CS. Acquired haemophilia: a natural history study of 16 patients \with factor VIII inhibitors receiving liltle or no therapy. Arch Intern Med 1987; 147- 1077-1081.
5. Shapiro SS. The immunologic character of acquired inhibitors of antihemophiliac globulin (factor VIII) and the kinetics of their interaction with factor VIII. J Clin Invest 1967: 46: 147-156.
6. Hover LW ed. Factor VIII inhibitors. New York: Alan R LISS (John Wiley) Progres Clin Biol Rech 1984: 73-85.
7. Fulcher CA. Immunochemistry of factor VHP C inhibitor antibodies. Am J Med 1991. 91 (suppl 5A): 6-8.
8. Soriano RM, Matthews JW. Guerado-Parro E. Adquired haemophilia and rheumatoid arthritis. Br J Rheumatol 1987: 26: 318-331
9. Hullin MB. Adqiured inhibitors in malignant and nonmalignanl disease satates. Am J Med 1991: 91 (suppl 5A): 9 13.
10. Coller BS, Hultin MB, Hoyer LW, Millr F, Dobbs JV, Dosik MH, et al. Normal pregnancy in a patient with a prior postpartum factor VIII inhibitor: with observations on pathogenesis and prognosis. Blood 1981.58:619-624
11. Green D. Lechner K. A sui vey of 215 non-hemophilic patients with inhibitors to factor VIII Thromb Haemost 1981: 54: 200-203.
12. Green D. Spontaneous inhibitors of Factor VIII. Br J Haematol 1968: 15: 57-75.
13. Vivaldi P, Savino M, Mazzon C, Rubertelli M. A hemorraghic syndrome of theelderly patient caused by antifactor VIII antibodies. Haematologica 1993; 78: 245-248
14. Kessler CM. An introduction to factor VIII inhibitors: the detection and quantitation. Am Med 1991. 91 (suppl 5a) 1-5.
15. ] 5. Morrison AE. Ludman CA. Annotation. Acquired haemophlia and its managements. Br J Haematol 1995: 89: 231-236.
16. Majado MJ. Tamayo M, Funes C. Sánchez-Peñas A, Gonzalez C, Sánchez J.Trescasosde inhibidordel factor VIII adquirido posparlo. Sangre 1991; 36: 239-241.
17. Sultan Y. Kazatchkine MD, Maisonneuve P, Nydegger UE. Antiidiotypic suppression to autoantibodies of factor Vin by high dose intravenous gammaglobulin. Lancet 1984, ii: 765-768.
18. Sultan Y. Kazatchkine D, Nydegger U, Rossi F, Dietrich G, Algiman M. Intravenous immunoglobulin in the treatment of spontaneoulsy acquired factor VIII: C inhibitors. Am J Med 1991:91 (suppl 5A): 35- 39.
19. Spero JA, Lewis JH, Hasiba U. Corticosteroid therapy for acquired FVIII: C inhibitors. Br J Haematoi 1981; 48: 337-351.
20. Green D. Factor VIII antibodies immunosuppressive therapy. Acad Sci 1975; 240: 389-399.
21. Nilsson IM, Hcdner V, Bjorlin G. Suppression of factor VIII antibody in hemophilia B by factor IX and cyclophosphamide and prednisone. Ann Intern Med 1973, 78: 91-95.
22. Herbst KD, Rappart SI, Kenoyer DG, Stanton W, Feinstein DI. Syndrome of an acquired inhibitor of factor VIII responsive to cyclophosphamide and prednisone. Ann Intern Med 1981; 95: 575-578.
23. Lian E. Larcada A, Chiu A. Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor. Ann Intern Med 1989; 10: 774-778.
24. Gren D. Suppression of antibody to factor VIII by combination of factor VIII andcyclophoshamide. Blood 1971; l- 11-17.
25. Brackmann HH: Induced immunotolerance in factor VIII inhibitor patients. Prog Clin Biol Res 1984; 150; 181-195.
26. Nilsson IM, Berntorp E, Zittervall O. Induction of immune tolerance in patients with hemophilia and antibodies to fator VIII by combined treatment with intravenous IgG cyclophosphamide and factor VIII. N Engl J Med 1988; 318: 947-950.
27. Lozier JN, Santagostino E. Kasper CK, Teitel JM, Hay CRM. Use of porcine factor VIII for surgical procedures in hemophilia A patients with inhibitors. Semin Hematol 1993; 30: 10-21.
28. Gordom EM, Al-Batmji, Goldsmith JC. Continuous infusion of monoclonal antibody-purified factor VIII rational approach to serious hemorrhage in patients with allo/autoantibodies to factor VIII. Am J Hematol 1994; 45: 142-145
29. Buenos S, Montoro JB, Martínez B, Altisent C, Tusell JM. Admimstracton de factor VIII a hemofilicos mediante bomba de perfusión continua. Med Clin 1991; 96: 364-366.